Abstract:. In updated phase I clinical trial results, patients treated with zoldonrasib, a KRASG12D-selective inhibitor under study in non–small cell lung cancer, showed an objective response rate of ...
Abstract. Integrin αvβ6 (ITGB6) is a heterodimer located on epithelial cell surfaces, upregulated during epithelial-mesenchymal transition (EMT), and overexpressed in various solid tumors, which is ...
Abstract. Results from the DRUP trial suggest that off-label targeted cancer therapies produce meaningful benefit primarily in tumors with well-validated biomarkers, such as MSI-H, echoing findings ...
Cancer Res (2026) 86 (7_Supplement): 5810.
You do not currently have access to this content.
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio ® (avelumab), a ...
Abstract A056: Bispecific T-cell engagers and antibody-drug conjugtes for the treatment of lymphomas
1Hays Documentation Specialists LLC, San Mateo, CA.
School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China. Search for other works by this author on: School of Pharmacy, Faculty of Medicine, The Chinese ...
Cancer Res (2025) 85 (8_Supplement_2): ND11.
Search for other works by this author on: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results